DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 019796
» See Plans and Pricing
The generic ingredient in ELOCON is mometasone furoate. There are thirty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 019796
Tradename: | ELOCON |
Applicant: | Merck Sharp Dohme |
Ingredient: | mometasone furoate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 019796
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 019796
Suppliers and Packaging for NDA: 019796
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ELOCON | mometasone furoate | LOTION;TOPICAL | 019796 | NDA | Merck Sharp & Dohme Corp. | 0085-0854 | 0085-0854-01 | 1 BOTTLE in 1 BOX (0085-0854-01) > 30 mL in 1 BOTTLE |
ELOCON | mometasone furoate | LOTION;TOPICAL | 019796 | NDA | Merck Sharp & Dohme Corp. | 0085-0854 | 0085-0854-02 | 1 BOTTLE in 1 BOX (0085-0854-02) > 60 mL in 1 BOTTLE |
Paragraph IV (Patent) Challenges for 019796
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
ELOCON | LOTION;TOPICAL | mometasone furoate | 019796 | 2004-06-10 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | LOTION;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Mar 30, 1989 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 019796
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck Sharp Dohme | ELOCON | mometasone furoate | LOTION;TOPICAL | 019796-001 | Mar 30, 1989 | Start Trial | Start Trial |
Merck Sharp Dohme | ELOCON | mometasone furoate | LOTION;TOPICAL | 019796-001 | Mar 30, 1989 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription